SCHEMBL6603374

SCHEMBL6603374

CC[Si](CC)(CC)OC1C(=O)N(C(=O)c2ccccc2)C1C1CC1

nearest known ligand 0.38

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
FOLH1 Q04609 1/20 0.38
KMT2A Q03164 2/20 0.38
MEN1 O00255 1/20 0.37
POLB P06746 1/20 0.37
TPSAB1 Q15661 1/20 0.37
TPSD1 Q9BZJ3 1/20 0.37
TPSG1 Q9NRR2 1/20 0.37
ACHE P22303 1/20 0.36
ALDH1A1 P00352 1/20 0.36
PTGDR2 Q9Y5Y4 1/20 0.35
TP53 P04637 1/20 0.35
BLM P54132 1/20 0.35
GAA P10253 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6603378 1.00 FOLH1 (0.38) FOLH1KMT2AMEN1POLBTPSAB1
SCHEMBL6603366 1.00 FOLH1 (0.38) FOLH1KMT2AMEN1POLBTPSAB1
SCHEMBL6602156 0.95 ALDH1A1 (0.38) FOLH1KMT2AMEN1POLBTPSAB1
SCHEMBL6602158 0.95 ALDH1A1 (0.38) FOLH1KMT2AMEN1POLBTPSAB1
SCHEMBL6602155 0.95 ALDH1A1 (0.38) FOLH1KMT2AMEN1POLBTPSAB1
SCHEMBL6601552 0.94 ALDH1A1 (0.38) FOLH1KMT2AMEN1POLBTPSAB1
SCHEMBL6601561 0.94 ALDH1A1 (0.38) FOLH1KMT2AMEN1POLBTPSAB1
SCHEMBL6601557 0.94 ALDH1A1 (0.38) FOLH1KMT2AMEN1POLBTPSAB1
SCHEMBL6977783 0.83 KMT2A (0.43) FOLH1KMT2AMEN1POLBTPSAB1
SCHEMBL6977780 0.83 KMT2A (0.43) FOLH1KMT2AMEN1POLBTPSAB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0667772-B9 TAXANES HAVING AN ALKYL SUBSTITUTED SIDE-CHAIN AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM UNIV FLORIDA STATE (US) 2004-08-04 EP disclosed
US-20030187061-A1 Antitumor agnets; antileukemia agents FLORIDA STATE UNIVERSITY 2003-10-02 US disclosed
EP-0667772-B1 TAXANES HAVING AN ALKYL SUBSTITUTED SIDE-CHAIN AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM UNIV FLORIDA STATE (US) 2003-05-14 EP disclosed
US-6521660-B2 Anticancer, antitumor agents FLORIDA STATE UNIVERSITY 2003-02-18 US disclosed
US-20020147335-A1 Taxanes having an alkyl substituted side-chain and pharmaceutical compositions containing them FLORIDA STATE UNIVERSITY 2002-10-10 US disclosed
EP-0667772-A4 TAXANES HAVING AN ALKYL SUBSTITUTED SIDE-CHAIN AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. UNIV FLORIDA STATE (US) 1995-12-20 EP disclosed
EP-0667772-A1 TAXANES HAVING AN ALKYL SUBSTITUTED SIDE-CHAIN AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM FLORIDA STATE UNIVERSITY (US) 1995-08-23 EP disclosed
WO-1994010997-A1 TAXANES HAVING AN ALKYL SUBSTITUTED SIDE-CHAIN AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM FLORIDA STATE UNIVERSITY (US) 1994-05-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030187061-A1 Antitumor agnets; antileukemia agents MCL1, TP53, EWSR1 FOLH1 3240/4885KMT2A 574/4885MEN1 959/4885
US-20020147335-A1 Taxanes having an alkyl substituted side-chain and pharmaceutical compositions containing them TOP2A, TOP2B, TUBB3 FOLH1 1121/4885KMT2A 2652/4885MEN1 2145/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.